List of Contents

Healthcare Distribution Market Size, Share, and Trends 2024 to 2034

The global healthcare distribution market size was USD 1.04 trillion in 2023, estimated at USD 1.11 trillion in 2024 and is anticipated to reach around USD 2.20 trillion by 2034, expanding at a CAGR of 7.10% from 2024 to 2034.

  • Last Updated : August 2024
  • Report Code : 1259
  • Category : Healthcare

 

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Healthcare Distribution Market, By Product

7.1. Healthcare Distribution Market, by Product Type, 2024-2034

7.1.1. Biopharmaceutical

7.1.1.1. Market Revenue and Forecast (2021-2034)

7.1.2. Pharmaceutical

7.1.2.1. Market Revenue and Forecast (2021-2034)

7.1.3. Medical Device

7.1.3.1. Market Revenue and Forecast (2021-2034)

7.1.4. Others

7.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 8. Global Healthcare Distribution Market, By Application

8.1. Healthcare Distribution Market, by Application, 2024-2034

8.1.1. Hospital Pharmacies

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Retail Pharmacies

8.1.2.1. Market Revenue and Forecast (2021-2034)

8.1.3. Others

8.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Healthcare Distribution Market, Regional Estimates and Trend Forecast

9.1. North America

9.1.1. Market Revenue and Forecast, by Product (2021-2034)

9.1.2. Market Revenue and Forecast, by Application (2021-2034)

9.1.3. U.S.

9.1.3.1. Market Revenue and Forecast, by Product (2021-2034)

9.1.3.2. Market Revenue and Forecast, by Application (2021-2034)

9.1.4. Rest of North America

9.1.4.1. Market Revenue and Forecast, by Product (2021-2034)

9.1.4.2. Market Revenue and Forecast, by Application (2021-2034)

9.2. Europe

9.2.1. Market Revenue and Forecast, by Product (2021-2034)

9.2.2. Market Revenue and Forecast, by Application (2021-2034)

9.2.3. UK

9.2.3.1. Market Revenue and Forecast, by Product (2021-2034)

9.2.3.2. Market Revenue and Forecast, by Application (2021-2034)

9.2.4. Germany

9.2.4.1. Market Revenue and Forecast, by Product (2021-2034)

9.2.4.2. Market Revenue and Forecast, by Application (2021-2034)

9.2.5. France

9.2.5.1. Market Revenue and Forecast, by Product (2021-2034)

9.2.5.2. Market Revenue and Forecast, by Application (2021-2034)

9.2.6. Rest of Europe

9.2.6.1. Market Revenue and Forecast, by Product (2021-2034)

9.2.6.2. Market Revenue and Forecast, by Application (2021-2034)

9.3. APAC

9.3.1. Market Revenue and Forecast, by Product (2021-2034)

9.3.2. Market Revenue and Forecast, by Application (2021-2034)

9.3.3. India

9.3.3.1. Market Revenue and Forecast, by Product (2021-2034)

9.3.3.2. Market Revenue and Forecast, by Application (2021-2034)

9.3.4. China

9.3.4.1. Market Revenue and Forecast, by Product (2021-2034)

9.3.4.2. Market Revenue and Forecast, by Application (2021-2034)

9.3.5. Japan

9.3.5.1. Market Revenue and Forecast, by Product (2021-2034)

9.3.5.2. Market Revenue and Forecast, by Application (2021-2034)

9.3.6. Rest of APAC

9.3.6.1. Market Revenue and Forecast, by Product (2021-2034)

9.3.6.2. Market Revenue and Forecast, by Application (2021-2034)

9.4. MEA

9.4.1. Market Revenue and Forecast, by Product (2021-2034)

9.4.2. Market Revenue and Forecast, by Application (2021-2034)

9.4.3. GCC

9.4.3.1. Market Revenue and Forecast, by Product (2021-2034)

9.4.3.2. Market Revenue and Forecast, by Application (2021-2034)

9.4.4. North Africa

9.4.4.1. Market Revenue and Forecast, by Product (2021-2034)

9.4.4.2. Market Revenue and Forecast, by Application (2021-2034)

9.4.5. South Africa

9.4.5.1. Market Revenue and Forecast, by Product (2021-2034)

9.4.5.2. Market Revenue and Forecast, by Application (2021-2034)

9.4.6. Rest of MEA

9.4.6.1. Market Revenue and Forecast, by Product (2021-2034)

9.4.6.2. Market Revenue and Forecast, by Application (2021-2034)

9.5. Latin America

9.5.1. Market Revenue and Forecast, by Product (2021-2034)

9.5.2. Market Revenue and Forecast, by Application (2021-2034)

9.5.3. Brazil

9.5.3.1. Market Revenue and Forecast, by Product (2021-2034)

9.5.3.2. Market Revenue and Forecast, by Application (2021-2034)

9.5.4. Rest of LATAM

9.5.4.1. Market Revenue and Forecast, by Product (2021-2034)

9.5.4.2. Market Revenue and Forecast, by Application (2021-2034)

Chapter 10. Company Profiles

10.1. AmerisourceBergen Corporation

10.1.1. Company Overview

10.1.2. Product Offerings

10.1.3. Financial Performance

10.1.4. Recent Initiatives

10.2. McKesson Corporation

10.2.1. Company Overview

10.2.2. Product Offerings

10.2.3. Financial Performance

10.2.4. Recent Initiatives

10.3. Medline Industries

10.3.1. Company Overview

10.3.2. Product Offerings

10.3.3. Financial Performance

10.3.4. Recent Initiatives

10.4. Cardinal Health, Inc.

10.4.1. Company Overview

10.4.2. Product Offerings

10.4.3. Financial Performance

10.4.4. Recent Initiatives

10.5. PHOENIX Group

10.5.1. Company Overview

10.5.2. Product Offerings

10.5.3. Financial Performance

10.5.4. Recent Initiatives

10.6. Shanghai Pharmaceutical Group Co., Ltd.

10.6.1. Company Overview

10.6.2. Product Offerings

10.6.3. Financial Performance

10.6.4. Recent Initiatives

10.7. Henry Schein Inc.

10.7.1. Company Overview

10.7.2. Product Offerings

10.7.3. Financial Performance

10.7.4. Recent Initiatives

10.8. Owens & Minor, Inc.

10.8.1. Company Overview

10.8.2. Product Offerings

10.8.3. Financial Performance

10.8.4. Recent Initiatives

10.9. Medline Industries

10.9.1. Company Overview

10.9.2. Product Offerings

10.9.3. Financial Performance

10.9.4. Recent Initiatives

10.10. Rochester Drug Cooperative, Inc.

10.10.1. Company Overview

10.10.2. Product Offerings

10.10.3. Financial Performance

10.10.4. Recent Initiatives

Chapter 11. Research Methodology

11.1. Primary Research

11.2. Secondary Research

11.3. Assumptions

Chapter 12. Appendix

12.1. About Us

12.2. Glossary of Terms

 

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

According to Precedence Research, the global healthcare distribution market value reached at USD 1.04 trillion in 2023 and is predicted to reach USD 2.20 trillion by the end of 2034.

The global healthcare distribution market is representing impressive CAGR of 7.10% over the forecast period 2024 to 2034.

Factors such as rising incidence of chronic diseases and rapid progress of medical devices industry is driving the growth of healthcare distribution market. The frequency of chronic diseases has risen quickly in past few years due to increasing geriatric population globally. As per the WHO data, the prevalence of chronic disease will surge to 57% by 2021. This growth is expected to be the most substantial in the developing nations. A suitable healthcare distribution structure is therefore essential around the world, and has become a requirement. A synchronized and robust healthcare response is essential in every part of the world. Chronic diseases are some of the most rampant and expensive health conditions in the United States.Approximately half of all American people suffer from a minimu

Pharmaceutical segment recorded the prime market share in the global healthcare distribution Market in 2020. The key reason for the hefty share of the pharmaceutical segment is the high production of pharmaceutical products owing to high demand, strong product pipeline of major manufacturers, high investment in research and development for developing effective drugs, initiatives taken by governments for eradicating communicable diseases, and constant launch of new and effective treatments.

In 2023, North America dominated the global market with a market share of more than 43%.

Asia-Pacific is anticipated to witness the rapid growth rate, on account of increasing healthcare expenditure and growing investment by major manufactures to streamline supply chain.

The major companies operating in the worldwide healthcare distribution are Amerisource Bergen Corporation, McKesson Corporation, Medline Industries, Cardinal Health, Inc., PHOENIX Group, Shanghai Pharmaceutical Group Co., Ltd., Henry Schein Inc., Owens & Minor, Inc., Medline Industries, and Rochester Drug Cooperative, Inc.among others.

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us